Ben Zhao, Ph.D.

Ben Zhao, Ph.D.

President & Founder

Ph.D. in Pharmaceutical Science, Ohio State University

Engaged in the research of drug delivery technology for 20+ years

Former FDA Senior Reviewer, CMC Expert; responsible for the approval of complex drugs, including nucleic acids, peptides, liposomes and cGMP quality system

Meng Xiaofeng  Ph.D/MBA

Meng Xiaofeng Ph.D/MBA

Co-president

PhD /MBA from the State University of New Jersey, Master from Shanghai Institute of Pharmaceutical Industry

More than 20 years of senior experience in the pharmaceutical industry, international regulatory registration and GMP field of authoritative experts

Good at drug development management, international regulatory registration, quality system construction and global market development. He has led the listing of many new drugs and more than 100 generic drugs in Europe and the United States, and promoted Chinese OTC softgel drugs to enter the mainstream channel in the United States

Robert J. Lee, Ph.D.

Robert J. Lee, Ph.D.

Chief Scientist

Tenured Professor, Ohio State University

Expert in liposome/nanoparticle delivery system, targeted drug delivery system, non-viral gene delivery system, and small nucleic acid delivery system

Angela Men, M.D., Ph.D.

Angela Men, M.D., Ph.D.

Chief Medical Officer

Ph.D. in Pharmaceutical Science, Virginia State University

Clinical Medicine of Tianjin Medical University/Resident Physician at the Second Hospital of Tianjin Medical University

Previously served as a Senior, Special Approving Officer and Head of the Drug Approval Team of the US FDA Center for Drug Approval